Michael Koziolek

2.7k total citations · 1 hit paper
74 papers, 1.6k citations indexed

About

Michael Koziolek is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Hematology. According to data from OpenAlex, Michael Koziolek has authored 74 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 19 papers in Nephrology and 14 papers in Hematology. Recurrent topics in Michael Koziolek's work include Heart Rate Variability and Autonomic Control (14 papers), Blood Pressure and Hypertension Studies (13 papers) and Chronic Kidney Disease and Diabetes (8 papers). Michael Koziolek is often cited by papers focused on Heart Rate Variability and Autonomic Control (14 papers), Blood Pressure and Hypertension Studies (13 papers) and Chronic Kidney Disease and Diabetes (8 papers). Michael Koziolek collaborates with scholars based in Germany, United States and Switzerland. Michael Koziolek's co-authors include Gerhard A. Müller, Manuel Wallbach, Frank Strutz, Carsten Bramlage, Radovan Vasko, Rolf Wachter, Antonia Zapf, Bernd Kitze, Stephan Lüders and Malte Heeg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Kidney International.

In The Last Decade

Michael Koziolek

74 papers receiving 1.5k citations

Hit Papers

The antifibrotic effects of relaxin in human renal fibrob... 2005 2026 2012 2019 2005 40 80 120

Peers

Michael Koziolek
Michael Koziolek
Citations per year, relative to Michael Koziolek Michael Koziolek (= 1×) peers Marina Κita

Countries citing papers authored by Michael Koziolek

Since Specialization
Citations

This map shows the geographic impact of Michael Koziolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Koziolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Koziolek more than expected).

Fields of papers citing papers by Michael Koziolek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Koziolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Koziolek. The network helps show where Michael Koziolek may publish in the future.

Co-authorship network of co-authors of Michael Koziolek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Koziolek. A scholar is included among the top collaborators of Michael Koziolek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Koziolek. Michael Koziolek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallbach, Manuel, et al.. (2024). Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonography. Clinical Kidney Journal. 17(9). 2 indexed citations
2.
Sato, Ryosuke, Michael Koziolek, & Stephan von Haehling. (2024). Translating evidence into practice: Managing electrolyte imbalances and iron deficiency in heart failure. European Journal of Internal Medicine. 131. 15–26. 3 indexed citations
3.
Sandek, Anja, Hassan Dihazi, Gry H. Dihazi, et al.. (2024). Urinary Dickkopf‐3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart Failure. Journal of the American Heart Association. 13(23). e036637–e036637. 3 indexed citations
4.
Schrader, B., Stephan Lüders, Bernhard Vaske, et al.. (2022). Regular Exercise is Associated with a More Favorable Cardiovascular Risk Profile, Better Quality of Life, Less Depression and Less Psychological Stress. SHILAP Revista de lepidopterología. 6 indexed citations
5.
Taylan, Christina, Claus Peter Schmitt, Lars Pape, et al.. (2020). Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis. The American Journal of Cardiology. 136. 38–48. 7 indexed citations
6.
Grupp, Clemens, et al.. (2019). Thrombophilic risk factors in hemodialysis: Association with early vascular access occlusion and patient survival in long-term follow-up. PLoS ONE. 14(9). e0222102–e0222102. 9 indexed citations
7.
Wallbach, Manuel, Björn Tampe, Hassan Dihazi, & Michael Koziolek. (2019). Akute Nierenschädigung: von Kreatinin zu KIM‑1?. Der Internist. 60(6). 578–586. 2 indexed citations
8.
Lipphardt, Mark, et al.. (2019). Effect of baroreflex activation therapy on renal sodium excretion in patients with resistant hypertension. Clinical Research in Cardiology. 108(11). 1287–1296. 5 indexed citations
9.
Wallbach, Manuel, Marcel Halbach, Hannes Reuter, et al.. (2016). Baroreflex activation therapy in patients with prior renal denervation. Journal of Hypertension. 34(8). 1630–1638. 20 indexed citations
10.
Patschan, Daniel, et al.. (2014). CD4+lymphocyte adenosine triphosphate - a new marker in sepsis with acute kidney injury?. BMC Nephrology. 15(1). 203–203. 3 indexed citations
11.
Patschan, Susann, Daniel Patschan, Peter Korsten, et al.. (2011). Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD). Critical Care. 15(2). R94–R94. 53 indexed citations
12.
Mueller, Gerhard, Katharina Lange, Victor W. Armstrong, et al.. (2011). Lipid‐apheresis improves microcirculation of the upper limbs. Journal of Clinical Apheresis. 26(4). 167–173. 11 indexed citations
13.
Bramlage, Carsten, Gerhard A. Müller, Björn Tampe, et al.. (2011). The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis. Journal of Nephrology. 24(5). 647–655. 17 indexed citations
14.
Vasko, Radovan, Michael Koziolek, Masami Ikehata, et al.. (2009). Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts. American Journal of Physiology-Renal Physiology. 296(6). F1452–F1463. 20 indexed citations
15.
Koziolek, Michael, Antonia Zapf, Carsten Bramlage, et al.. (2009). Retrospective Analysis of Long‐term Lipid Apheresis at a Single Center. Therapeutic Apheresis and Dialysis. 14(2). 143–152. 40 indexed citations
16.
Bramlage, Carsten, K. Schröder, Peter Bramlage, et al.. (2009). Predictors of complications in therapeutic plasma exchange. Journal of Clinical Apheresis. 24(6). 225–231. 62 indexed citations
17.
Koziolek, Michael, Radovan Vasko, Carsten Bramlage, Gerhard A. Müller, & Frank Strutz. (2009). The CX3C-Chemokine Fractalkine in Kidney Diseases. Mini-Reviews in Medicinal Chemistry. 9(10). 1215–1228. 16 indexed citations
18.
Bramlage, Carsten, Christian Kaps, Ute Ungethüm, et al.. (2008). Modulatory effects of inflammation and therapy on GDF‐5 expression in rheumatoid arthritis synovium. Scandinavian Journal of Rheumatology. 37(6). 401–409. 16 indexed citations
19.
Koziolek, Michael, Peter F. Zipfel, Christine Skerka, et al.. (2008). Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3). Kidney International. 74(3). 384–388. 8 indexed citations
20.
Scheel, Alexander, Volker Schettler, Michael Koziolek, et al.. (2004). Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study. Atherosclerosis. 174(1). 133–139. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026